These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 32062701)

  • 1. DDAPRED: a computational method for predicting drug repositioning using regularized logistic matrix factorization.
    Wang X; Yan R
    J Mol Model; 2020 Feb; 26(3):60. PubMed ID: 32062701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Computational drug repositioning based on multi-similarities bilinear matrix factorization.
    Yang M; Wu G; Zhao Q; Li Y; Wang J
    Brief Bioinform; 2021 Jul; 22(4):. PubMed ID: 33147616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved anticancer drug response prediction in cell lines using matrix factorization with similarity regularization.
    Wang L; Li X; Zhang L; Gao Q
    BMC Cancer; 2017 Aug; 17(1):513. PubMed ID: 28768489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug Repositioning by Integrating Known Disease-Gene and Drug-Target Associations in a Semi-supervised Learning Model.
    Le DH; Nguyen-Ngoc D
    Acta Biotheor; 2018 Dec; 66(4):315-331. PubMed ID: 29700660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DR2DI: a powerful computational tool for predicting novel drug-disease associations.
    Lu L; Yu H
    J Comput Aided Mol Des; 2018 May; 32(5):633-642. PubMed ID: 29687309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Additional Neural Matrix Factorization model for computational drug repositioning.
    Yang X; Zamit L; Liu Y; He J
    BMC Bioinformatics; 2019 Aug; 20(1):423. PubMed ID: 31412762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NTD-DR: Nonnegative tensor decomposition for drug repositioning.
    Jamali AA; Tan Y; Kusalik A; Wu FX
    PLoS One; 2022; 17(7):e0270852. PubMed ID: 35862409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug repositioning through integration of prior knowledge and projections of drugs and diseases.
    Xuan P; Cao Y; Zhang T; Wang X; Pan S; Shen T
    Bioinformatics; 2019 Oct; 35(20):4108-4119. PubMed ID: 30865257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved Computational Drug-Repositioning by Self-Paced Non-Negative Matrix Tri-Factorization.
    Dang Q; Liang Y; Ouyang D; Miao R; Ling C; Liu X; Xie S
    IEEE/ACM Trans Comput Biol Bioinform; 2023; 20(3):1953-1962. PubMed ID: 36445996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug repositioning based on comprehensive similarity measures and Bi-Random walk algorithm.
    Luo H; Wang J; Li M; Luo J; Peng X; Wu FX; Pan Y
    Bioinformatics; 2016 Sep; 32(17):2664-71. PubMed ID: 27153662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting drug-target interactions using matrix factorization with self-paced learning and dual similarity information.
    Ling C; Zeng T; Dang Q; Liang Y; Liu X; Xie S
    Technol Health Care; 2024; 32(S1):49-64. PubMed ID: 38759038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug repositioning based on multi-view learning with matrix completion.
    Yan Y; Yang M; Zhao H; Duan G; Peng X; Wang J
    Brief Bioinform; 2022 May; 23(3):. PubMed ID: 35289352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparative benchmarking and evaluation framework for heterogeneous network-based drug repositioning methods.
    Li Y; Yang Y; Tong Z; Wang Y; Mi Q; Bai M; Liang G; Li B; Shu K
    Brief Bioinform; 2024 Mar; 25(3):. PubMed ID: 38647153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DRIMC: an improved drug repositioning approach using Bayesian inductive matrix completion.
    Zhang W; Xu H; Li X; Gao Q; Wang L
    Bioinformatics; 2020 May; 36(9):2839-2847. PubMed ID: 31999326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MultiDTI: drug-target interaction prediction based on multi-modal representation learning to bridge the gap between new chemical entities and known heterogeneous network.
    Zhou D; Xu Z; Li W; Xie X; Peng S
    Bioinformatics; 2021 Dec; 37(23):4485-4492. PubMed ID: 34180970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug repositioning for enzyme modulator based on human metabolite-likeness.
    Lee YH; Choi H; Park S; Lee B; Yi GS
    BMC Bioinformatics; 2017 May; 18(Suppl 7):226. PubMed ID: 28617219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integration of various protein similarities using random forest technique to infer augmented drug-protein matrix for enhancing drug-disease association prediction.
    Kitsiranuwat S; Suratanee A; Plaimas K
    Sci Prog; 2022; 105(3):368504221109215. PubMed ID: 35801312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In silico drug repositioning based on the integration of chemical, genomic and pharmacological spaces.
    Chen H; Zhang Z; Zhang J
    BMC Bioinformatics; 2021 Feb; 22(1):52. PubMed ID: 33557749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A network-based drug repurposing method via non-negative matrix factorization.
    Sadeghi S; Lu J; Ngom A
    Bioinformatics; 2022 Feb; 38(5):1369-1377. PubMed ID: 34875000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. iDrug: Integration of drug repositioning and drug-target prediction via cross-network embedding.
    Chen H; Cheng F; Li J
    PLoS Comput Biol; 2020 Jul; 16(7):e1008040. PubMed ID: 32667925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.